Published in Biochem J on March 15, 1995
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem (1961) 59.20
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (1984) 17.70
Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. Biochim Biophys Acta (1966) 16.27
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (1984) 14.21
Detection and quantification of phosphotyrosine in proteins. Methods Enzymol (1983) 11.89
Growth factor receptor tyrosine kinases. Annu Rev Biochem (1988) 8.67
Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol (1987) 6.41
Characterization of Rous sarcoma virus src gene products synthesized in vitro. J Virol (1978) 6.39
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell (1987) 5.80
MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY. Biochemistry (1964) 5.75
Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res (1985) 5.57
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (1987) 3.75
Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol (1991) 3.33
Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry (1987) 3.20
Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem J (1977) 2.88
All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J Biol Chem (1989) 2.46
Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem (1985) 2.22
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci U S A (1987) 2.10
Convex constraint analysis: a natural deconvolution of circular dichroism curves of proteins. Protein Eng (1991) 1.83
Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J Biol Chem (1984) 1.80
Detection and purification of a recombinant human B lymphotropic virus (HHV-6) in the baculovirus expression system by limiting dilution and DNA dot-blot hybridization. J Virol Methods (1988) 1.65
Expression of the human EGF receptor with ligand-stimulatable kinase activity in insect cells using a baculovirus vector. EMBO J (1988) 1.46
Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism. J Biol Chem (1988) 1.38
Properties of a monoclonal antibody to epidermal growth factor receptor with implications for the mechanism of action of EGF. EMBO J (1984) 1.34
Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. II. Plastocyanin. J Mol Biol (1992) 1.29
Design and use of peptide substrates for protein kinases. Methods Enzymol (1991) 1.28
Identification of a novel autophosphorylation site (P4) on the epidermal growth factor receptor. Biochem J (1989) 1.28
Analysis of very late gene expression by Autographa californica nuclear polyhedrosis virus and the further development of multiple expression vectors. J Gen Virol (1990) 1.25
Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. Biochemistry (1985) 1.21
Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor. J Biol Chem (1989) 1.20
The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. J Biol Chem (1994) 1.17
The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells. J Biol Chem (1983) 1.16
Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization. Biochemistry (1992) 1.15
Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization. J Biol Chem (1988) 1.05
Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. Biochemistry (1993) 1.05
Activation of the EGF receptor tyrosine kinase by divalent metal ions: comparison of holoreceptor and isolated kinase domain properties. Biochim Biophys Acta (1990) 1.05
Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. Arch Biochem Biophys (1992) 1.04
EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. J Biol Chem (1991) 1.02
Identification of the N and NSS proteins coded by the ambisense S RNA of Punta Toro phlebovirus using monospecific antisera raised to baculovirus expressed N and NSS proteins. Virology (1987) 0.97
Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity. Cell Growth Differ (1990) 0.95
New insights into protein-tyrosine kinase receptor signaling complexes. Protein Sci (1993) 0.94
Beta poly(L-lysine): a model system for biological self-assembly. J Mol Biol (1974) 0.85
The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem (1994) 0.83
Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors. Eur J Biochem (1992) 0.83
Assay of growth factor-stimulated tyrosine kinases using synthetic peptide substrates. Methods Enzymol (1987) 0.82
Potentiation of epidermal growth factor receptor protein-tyrosine kinase activity by sulfate. Biochim Biophys Acta (1992) 0.81
A rapid assay for protein kinases phosphorylating small polypeptides and other substrates. Anal Biochem (1983) 0.78
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell (1996) 9.10
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature (1997) 5.47
A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. Physiol Genomics (2001) 4.50
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell (1995) 4.13
Active observation in management of acute abdominal pain in childhood. Br Med J (1976) 3.71
Structural and mechanistic basis of immunity toward endonuclease colicins. Nat Struct Biol (1999) 3.37
Acute abdominal pain in childhood: analysis of a year's admissions. Br Med J (1967) 2.98
Detection of transient protein folding populations by mass spectrometry. Science (1993) 2.85
Responsive gels formed by the spontaneous self-assembly of peptides into polymeric beta-sheet tapes. Nature (1997) 2.69
Acute abdominal pain in childhood, with special reference to cases not due to acute appendicitis. Br Med J (1969) 2.59
Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry (2000) 2.47
Epidemiology and course of gastrointestinal haemorrhage in North-east Scotland. Br Med J (1973) 2.39
Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol (1985) 2.20
Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A (1992) 2.14
Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. J Mol Biol (1999) 1.97
A new family of mouse homeo box-containing genes: molecular structure, chromosomal location, and developmental expression of Hox-7.1. Genes Dev (1989) 1.93
Further haemorrhage after admission to hospital for gastrointestinal haemorrhage. Br Med J (1973) 1.92
Developmental regulation of expression and activity of multiple forms of the Drosophila RAC protein kinase. J Biol Chem (1995) 1.91
Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A (1999) 1.84
Understanding how proteins fold: the lysozyme story so far. Trends Biochem Sci (1994) 1.83
GroEL accelerates the refolding of hen lysozyme without changing its folding mechanism. Nat Struct Biol (1999) 1.81
Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol Cell Biol (1999) 1.79
Use of an Amplatz Goose Neck snare as a target for collateral neck vein dialysis catheter placement. J Vasc Interv Radiol (2001) 1.72
Ultrarapid mixing experiments reveal that Im7 folds via an on-pathway intermediate. Nat Struct Biol (2001) 1.72
WAM: an improved algorithm for modelling antibodies on the WEB. Protein Eng (2000) 1.67
Conformation of GroEL-bound alpha-lactalbumin probed by mass spectrometry. Nature (1994) 1.65
Computer use and applications in veterinary medicine. J Am Vet Med Assoc (1992) 1.64
The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1. J Biol Chem (1999) 1.64
A children's casualty department. Br Med J (1966) 1.62
Urinary tract infection in children. Br Med J (Clin Res Ed) (1984) 1.59
Recurrent adhesive small bowel obstruction. World J Surg (1985) 1.56
Emerging trends in the management of the impalpable testis. Br J Surg (1999) 1.54
ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int (2000) 1.53
Intra-operative colonic irrigation in the management of left-sided large bowel emergencies. Br J Surg (1985) 1.52
Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem (2000) 1.51
Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol (2001) 1.51
Epidermal growth factor receptors. Mol Cell Biochem (1981) 1.50
Modeling antibody hypervariable loops: a combined algorithm. Proc Natl Acad Sci U S A (1989) 1.50
High affinity epidermal growth factor receptors on the surface of A431 cells have restricted lateral diffusion. EMBO J (1984) 1.46
Aspirin and alcohol in gastrointestinal haemorrhage. Gut (1971) 1.46
Electric-field control of nonvolatile magnetization in Co40Fe40B20/Pb(Mg(1/3)Nb(2/3))(0.7)Ti(0.3)O3 structure at room temperature. Phys Rev Lett (2012) 1.44
Demonstration by NMR of folding domains in lysozyme. Nature (1991) 1.44
Investigation of protein folding by mass spectrometry. FASEB J (1996) 1.42
Outcome in colorectal carcinoma: seven-year study of a population. Br Med J (1980) 1.42
Immediate resection in the treatment of large bowel emergencies. Br J Surg (1978) 1.40
Operative intubation in the treatment of complicated small bowel obstruction. Br J Surg (1978) 1.36
Studies on the immunoglobulin-G Fc-fragment receptor from neonatal rat small intestine. Biochem J (1980) 1.35
Properties of a monoclonal antibody to epidermal growth factor receptor with implications for the mechanism of action of EGF. EMBO J (1984) 1.34
ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia (2010) 1.34
Tertiary interactions in the folding pathway of hen lysozyme: kinetic studies using fluorescent probes. Biochemistry (1994) 1.33
A partially folded state of hen egg white lysozyme in trifluoroethanol: structural characterization and implications for protein folding. Biochemistry (1993) 1.32
Active observation in acute abdominal pain. Am J Surg (1986) 1.31
Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol (2011) 1.31
2-Oxo acid dehydrogenase multi-enzyme complexes: in the beginning and halfway there. Biochem Soc Symp (1987) 1.29
Microarray experimental design: power and sample size considerations. Physiol Genomics (2003) 1.29
The hunchback and its neighbours: proline as an environmental modulator. Trends Biochem Sci (2001) 1.28
Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells. Nature (1979) 1.27
Fast and slow tracks in lysozyme folding: insight into the role of domains in the folding process. J Mol Biol (1997) 1.27
V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. J Immunol (1988) 1.26
Effects of repletion with zinc and other micronutrients on neuropsychologic performance and growth of Chinese children. Am J Clin Nutr (1998) 1.24
Anti-inflammatory effects of emodin from ventilago leiocarpa. Am J Chin Med (1996) 1.23
Dog and cat ownership, 1991-1998. J Am Vet Med Assoc (1994) 1.23
Amide hydrogen exchange in a highly denatured state. Hen egg-white lysozyme in urea. J Mol Biol (1994) 1.21
Practicalities in the management of the acute abdomen. Br J Surg (1990) 1.20
Protein folding mechanisms: new methods and emerging ideas. Curr Opin Struct Biol (2000) 1.19
The preparation of protected fragments of lysozyme for semisynthesis. Biochem J (1976) 1.18
Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc Natl Acad Sci U S A (1994) 1.17
Short elastin-like peptides exhibit the same temperature-induced structural transitions as elastin polymers: implications for protein engineering. J Mol Biol (1998) 1.17
Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. Biochem Biophys Res Commun (2000) 1.16
Subcellular distribution of the external and internal domains of the EGF receptor in A-431 cells. Exp Cell Res (1986) 1.15
Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology (1994) 1.12
The prediction and characterization of metal binding sites in proteins. Protein Eng (1993) 1.12
Stigmata: an algorithm to determine structural commonalities in diverse datasets. J Chem Inf Comput Sci (1996) 1.10
Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: evidence of DEP suppression of macrophage activity. J Toxicol Environ Health A (1999) 1.10
Hen egg white lysozyme expressed in, and secreted from, Aspergillus niger is correctly processed and folded. Biotechnology (N Y) (1990) 1.09
Veterinary service market for companion animals, 1992. Part I: Companion animal ownership and demographics. J Am Vet Med Assoc (1992) 1.08
Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering. Nature (1987) 1.07
Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett (1997) 1.07
Anti-inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med (1996) 1.07
Acidic conditions stabilise intermediates populated during the folding of Im7 and Im9. J Mol Biol (2001) 1.06
Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci (2001) 1.05
Gastrostomy in neonatal respiratory failure. Lancet (1966) 1.04
Site-directed mutagenesis of proteolytic antibody light chain. J Mol Biol (1995) 1.03
Trifluoroethanol may form a solvent matrix for assisted hydrophobic interactions between peptide side chains. Protein Eng (2000) 1.03
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia (2010) 1.03
An abdominal extraperitoneal approach for the difficult orchidopexy. Br J Surg (1979) 1.02
Acute cholecystitis: a case for early surgery? Br Med J (Clin Res Ed) (1982) 1.02
Hydrogen exchange properties of proteins in native and denatured states monitored by mass spectrometry and NMR. Protein Sci (1997) 1.02
Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif (2009) 1.02
Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ (1993) 1.02
The presentation of gastrointestinal lymphoma: study of a population. Br J Surg (1979) 1.01
Radioimmunoassay of cocaine in hair: concise communication. J Nucl Med (1982) 1.01
Significant hydrogen exchange protection in GroEL-bound DHFR is maintained during iterative rounds of substrate cycling. Protein Sci (1996) 1.01
Diffuse xanthogranulomatous pyelonephritis in children: an unrecognized variant. J Urol (1977) 1.01
Pseudospecific docking surfaces on electron transfer proteins as illustrated by pseudoazurin, cytochrome c550 and cytochrome cd1 nitrite reductase. Nat Struct Biol (1995) 1.00
Evaluation of the anti-inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats. Am J Chin Med (1993) 1.00
Role of the single disulphide bond of beta(2)-microglobulin in amyloidosis in vitro. Protein Sci (2001) 0.99